Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.

The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

OMRF opens Center for Biomedical Data Sciences to boost AI-driven research on diseases like lupus and Alzheimer’s across ...

Market Overview: The North American autoimmune disease diagnostics market encompasses a wide range of diseases, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. These ...

Plump, pouty lips are everywhere—from social media filters to celebrity red carpets. But behind the glossy aesthetic of lip ...

Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...

The steady growth trajectory of Europe’s autoimmune disease diagnostics market can be attributed to several factors. Primarily, the rising incidence of autoimmune disorders across the region ...